Predictors of Major Atrial Fibrillation Endpoints in the National Heart, Lung, and Blood Institute HCMR

Guttmann, 2017, Predictors of atrial fibrillation in hypertrophic cardiomyopathy, Heart, 103, 672, 10.1136/heartjnl-2016-309672 Siontis, 2014, Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical correlations, and mortality in a large high-risk population, J Am Heart Assoc, 3 Maron, 2018, Clinical course and management of hypertrophic cardiomyopathy, N Engl J Med, 379, 655, 10.1056/NEJMra1710575 Ommen, 2020, 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines, J Am Coll Cardiol, 76, e159, 10.1016/j.jacc.2020.08.045 Hindricks, 2021, 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS), Eur Heart J, 42, 373, 10.1093/eurheartj/ehaa612 Ho, 2018, Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe), Circulation, 138, 1387, 10.1161/CIRCULATIONAHA.117.033200 Rowin, 2017, Clinical profile and consequences of atrial fibrillation in hypertrophic cardiomyopathy, Circulation, 136, 2420, 10.1161/CIRCULATIONAHA.117.029267 Wilke, 2016, High incidence of de novo and subclinical atrial fibrillation in patients with hypertrophic cardiomyopathy and cardiac rhythm management device, J Cardiovasc Electrophysiol, 27, 779, 10.1111/jce.12982 Spirito, 2014, Risk of sudden death and outcome in patients with hypertrophic cardiomyopathy with benign presentation and without risk factors, Am J Cardiol, 113, 1550, 10.1016/j.amjcard.2014.01.435 Kramer, 2015, Hypertrophic Cardiomyopathy Registry: the rationale and design of an international, observational study of hypertrophic cardiomyopathy, Am Heart J, 170, 223, 10.1016/j.ahj.2015.05.013 Neubauer, 2019, Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM Registry, J Am Coll Cardiol, 74, 2333, 10.1016/j.jacc.2019.08.1057 van Buuren, 2012 Zou, 2005, Regularization and variable selection via the elastic net, J Royal Stat Soc Series B (Stat Method), 67, 301, 10.1111/j.1467-9868.2005.00503.x Austin, 2009, Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research, Commun Stat Simul Comput, 38, 7, 10.1080/03610910902859574 Yang, 2012 Fine, 1999, A proportional hazards model for the subdistribution of a competing risk, J Am Statistical Assoc, 94, 14, 10.1080/01621459.1999.10474144 Andersen, 2012, Competing risks in epidemiology: possibilities and pitfalls, Int J Epidemiol, 41, 861, 10.1093/ije/dyr213 Prentice, 1981, On the regression analysis of multivariate failure time data, Biometrika, 68, 373, 10.1093/biomet/68.2.373 Bagdonavicius, 2010, Goodness-of-fit criteria for the Cox model from left truncated and right censored data, J Mathematic Sci, 167, 8 Harrell, 2015 Olivotto, 2001, Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy, Circulation, 104, 2517, 10.1161/hc4601.097997 Butters, 2020, Epidemiology and clinical characteristics of atrial fibrillation in patients with inherited heart diseases, J Cardiovasc Electrophysiol, 31, 465, 10.1111/jce.14346 Staerk, 2017, Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes, Circ Res, 120, 1501, 10.1161/CIRCRESAHA.117.309732 Reineck, 2013, Physical activity and other health behaviors in adults with hypertrophic cardiomyopathy, Am J Cardiol, 111, 1034, 10.1016/j.amjcard.2012.12.018 Fumagalli, 2020, Association of obesity with adverse long-term outcomes in hypertrophic cardiomyopathy, JAMA Cardiol, 5, 65, 10.1001/jamacardio.2019.4268 Saberi, 2017, Effect of moderate-intensity exercise training on peak oxygen consumption in patients with hypertrophic cardiomyopathy: a randomized clinical trial, JAMA, 317, 1349, 10.1001/jama.2017.2503 Losi, 2004, Determinants of atrial fibrillation development in patients with hypertrophic cardiomyopathy, Am J Cardiol, 94, 895, 10.1016/j.amjcard.2004.06.024 Tani, 2004, Left atrial volume and the risk of paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy, J Am Soc Echocardiogr, 17, 644, 10.1016/j.echo.2004.02.010 Rabbat, 2015, Left atrial volume assessment in atrial fibrillation using multimodality imaging: a comparison of echocardiography, invasive three-dimensional CARTO and cardiac magnetic resonance imaging, Int J Cardiovasc Imaging, 31, 1011, 10.1007/s10554-015-0641-y Vasquez, 2019, Low left atrial strain is associated with adverse outcomes in hypertrophic cardiomyopathy patients, J Am Soc Echocardiogr, 32, 593, 10.1016/j.echo.2019.01.007 Paraskevaidis, 2009, Two-dimensional strain analysis in patients with hypertrophic cardiomyopathy and normal systolic function: a 12-month follow-up study, Am Heart J, 158, 444, 10.1016/j.ahj.2009.06.013 Debonnaire, 2017, Left atrial size and function in hypertrophic cardiomyopathy patients and risk of new-onset atrial fibrillation, Circ Arrhythm Electrophysiol, 10, 10.1161/CIRCEP.116.004052 Maron, 2014, Left atrial remodeling in hypertrophic cardiomyopathy and susceptibility markers for atrial fibrillation identified by cardiovascular magnetic resonance, Am J Cardiol, 113, 1394, 10.1016/j.amjcard.2013.12.045 Sivalokanathan, 2019, Hypertrophic cardiomyopathy patients with paroxysmal atrial fibrillation have a high burden of left atrial fibrosis by cardiac magnetic resonance imaging, J Am Coll Cardiol EP, 5, 364